Leading to better outcomes through improved medication safety and efficacy and lowered medical costs
Learn MoreScalable multi-omics data management, analysis, and exploration
Learn MoreIllumina offers webinars and free online training courses to get the most out of your experiments and products
View WebinarsView CoursesView trends over time for key run metrics such as yield, Q30, and more
Sign in or RegisterBringing to light the challenges and hopes for the rare disease community
Read ArticleDate | Publication | Title |
---|---|---|
Feb 25, 2021 | BioPharma Reporter | German program using whole genome sequencing to diagnose rare diseases and cancer risk |
Feb 25, 2021 | Kaiser Health News | Have a Case of a Covid Variant? No One Is Going to Tell You |
Feb 17, 2021 | Cambridge Independent | Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge |